BA
34
-4
STT
56
2
NVDA
44
-2
AA
31
3
PNW
52
2
LB
62
2
LNC
30
4
JNJ
51
12
PSX
32
2
LH
45
2
ETN
65
-2
AMAT
48
4
GILD
41
3
MSI
47
4
CNP
57
3
CAH
50
2
NWS
62
2
T
33
4
EQR
42
5
NUE
41
-2
BA
34
-4
STT
56
2
NVDA
44
-2
AA
31
3
PNW
52
2
LB
62
2
LNC
30
4
JNJ
51
12
PSX
32
2
LH
45
2
ETN
65
-2
AMAT
48
4
GILD
41
3
MSI
47
4
CNP
57
3
CAH
50
2
NWS
62
2
T
33
4
EQR
42
5
NUE
41
-2
Financhill
Back

The Trade Desk Vs. Intra-Cellular Therapies Industry Stock Comparison

Sell
45

TTD
The Trade Desk

Last Price:
$116.82
Seasonality Move:
12.62%
Buy
61

ITCI
Intra-Cellular Therapies

Last Price:
$126.86
Seasonality Move:
2.9%
Sell
45
The Trade Desk (TTD) is a Sell

Is The Trade Desk a Buy, Sell or Hold?

  • The current The Trade Desk [TTD] share price is $116.76. The Score for TTD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • TTD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Intra-Cellular Therapies (ITCI) is a Buy

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $126.89. The Score for ITCI is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • ITCI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TTD Stock Price Chart

What is The Trade Desk's stock price today?

  • The The Trade Desk share price today is $116.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TTD is experiencing selling pressure, which indicates risk of future bearish movement.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $126.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.

TTD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.59 Sell
Relative Strength Index (14 RSI): 38.28 Sell
Chaikin Money Flow: -1473043 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (119.22 - 132.32) Sell
Bollinger Bands (100): (107.83 - 128.69) Sell

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.34 Buy
Relative Strength Index (14 RSI): 87.18 Buy
Chaikin Money Flow: -9953478 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (76.29 - 99.79) Buy
Bollinger Bands (100): (72.19 - 89.87) Buy

TTD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 120.32 Sell
20-day SMA: 123.5 Sell
50-day SMA: 126.38 Sell
200-day SMA: 105.19 Buy
8-day EMA: 119.8 Sell
20-day EMA: 122.76 Sell
50-day EMA: 123.34 Sell
200-day EMA: 107.83 Buy

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 95.56 Buy
20-day SMA: 89.05 Buy
50-day SMA: 87.32 Buy
200-day SMA: 76.32 Buy
8-day EMA: 102.15 Buy
20-day EMA: 92.65 Buy
50-day EMA: 87.08 Buy
200-day EMA: 77.64 Buy

The Trade Desk Earnings Growth & TTD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $0.50 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and an increase next year of $3.13 per share.

The Trade Desk Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):